{"transactions":[{"id":1520647,"issuer":{"id":87239,"kind":"organization","name":"Notable Labs, Ltd.","symbol":"NTBL"},"owners":[{"id":16055,"kind":"person","name":"Graney Thomas","position":1,"cik":"0001618275","reported_name":"Graney Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-05-10T17:07:57.000Z","date":"2024-05-08","kind":"grant","planned":false,"acquired":true,"shares":40247,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Grant of restricted shares vesting in two equal annual installments from the date of grant."}],"balance_after":40247,"source":{"system":"sec-edgar","filing":"0001062993-24-009931","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618275/000106299324009931/form4.xml","form_type":"4"}},{"id":1669504,"issuer":{"id":87239,"kind":"organization","name":"Notable Labs, Ltd.","symbol":"NTBL"},"owners":[{"id":16055,"kind":"person","name":"Graney Thomas","position":1,"cik":"0001618275","reported_name":"Graney Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-01-26T11:04:24.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":9753,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests 50% on the first anniversary of date of grant and thereafter in four equal quarterly installments ending on the second anniversary of the date of grant."}],"balance_after":9753,"derivative":{"exercise_price":1.28,"expiration_date":"2034-01-24","underlying":"Ordinary Shares","underlying_shares":9753},"source":{"system":"sec-edgar","filing":"0001062993-24-001363","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618275/000106299324001363/form4.xml","form_type":"4"}},{"id":411570,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16055,"kind":"person","name":"Graney Thomas","position":1,"cik":"0001618275","reported_name":"Graney Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-10-02T20:24:22.000Z","date":"2018-10-01","kind":"sale","acquired":false,"shares":1076,"price":193.24,"value":207926.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Graney's company-approved trading plan under Rule 10b5-1."}],"balance_after":12430,"source":{"system":"sec-edgar","filing":"0001209191-18-053125","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118053125/doc4.xml","form_type":"4"}},{"id":419438,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16055,"kind":"person","name":"Graney Thomas","position":1,"cik":"0001618275","reported_name":"Graney Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-08T23:23:53.000Z","date":"2018-02-06","kind":"grant","acquired":true,"shares":10436,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in 16 quarterly installments from 2/6/2018."}],"balance_after":10436,"derivative":{"exercise_price":155.57,"expiration_date":"2028-02-05","underlying":"Common Stock","underlying_shares":10436},"source":{"system":"sec-edgar","filing":"0001209191-18-008548","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118008548/doc4.xml","form_type":"4"}},{"id":419437,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16055,"kind":"person","name":"Graney Thomas","position":1,"cik":"0001618275","reported_name":"Graney Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-02-08T23:23:53.000Z","date":"2018-02-06","kind":"grant","acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests in three equal installments on 2/17/2019, 2/17/2020 and 2/17/2021."}],"balance_after":13289,"source":{"system":"sec-edgar","filing":"0001209191-18-008548","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118008548/doc4.xml","form_type":"4"}},{"id":420748,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16055,"kind":"person","name":"Graney Thomas","position":1,"cik":"0001618275","reported_name":"Graney Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-01-03T21:49:43.000Z","date":"2018-01-02","kind":"sale","acquired":false,"shares":777,"price":149.95,"value":116511.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Graney's company-approved trading plan under Rule 10b5-1."}],"balance_after":8789,"source":{"system":"sec-edgar","filing":"0001209191-18-000968","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919118000968/doc4.xml","form_type":"4"}},{"id":423436,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16055,"kind":"person","name":"Graney Thomas","position":1,"cik":"0001618275","reported_name":"Graney Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-09-15T12:28:34.000Z","date":"2017-09-13","kind":"grant","acquired":true,"shares":9566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests as to 25% of the shares on December 31, 2017 and an additional 25% of the shares on each of September 30, 2018, 2019 and 2020."}],"balance_after":9566,"source":{"system":"sec-edgar","filing":"0001209191-17-052901","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919117052901/doc4.xml","form_type":"4"}},{"id":4414201,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":16055,"kind":"person","name":"Graney Thomas","position":1,"cik":"0001618275","reported_name":"Graney Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-03-01T18:28:01.000Z","date":"2017-02-27","kind":"grant","acquired":true,"shares":127500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option, granted as an annual performance award, vests as to 2.08333% of the shares of Class A Common Stock on each monthly anniversary of January 1, 2017."}],"balance_after":127500,"derivative":{"exercise_price":16.77,"expiration_date":"2027-02-27","underlying":"Class A Common Stock","underlying_shares":127500},"source":{"system":"sec-edgar","filing":"0001209191-17-016106","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1618275/000120919117016106/doc4.xml","form_type":"4"}},{"id":4414200,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":16055,"kind":"person","name":"Graney Thomas","position":1,"cik":"0001618275","reported_name":"Graney Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2017-03-01T18:28:01.000Z","date":"2017-02-27","kind":"grant","acquired":true,"shares":21250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof."}],"balance_after":42013,"source":{"system":"sec-edgar","filing":"0001209191-17-016106","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618275/000120919117016106/doc4.xml","form_type":"4"}},{"id":4424713,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":16055,"kind":"person","name":"Graney Thomas","position":1,"cik":"0001618275","reported_name":"Graney Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2017-02-24T16:37:25.000Z","date":"2017-02-22","kind":"sale","acquired":false,"shares":1417,"price":16.94,"value":24003.98,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on March 1, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.47 to $17.41, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":20763,"source":{"system":"sec-edgar","filing":"0001209191-17-014370","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1618275/000120919117014370/doc4.xml","form_type":"4"}},{"id":4424712,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":16055,"kind":"person","name":"Graney Thomas","position":1,"cik":"0001618275","reported_name":"Graney Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2017-02-24T16:37:25.000Z","date":"2017-02-22","kind":"sale","acquired":false,"shares":457,"price":16.94,"value":7741.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.  This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on March 16, 2015."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.47 to $17.41, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":22180,"source":{"system":"sec-edgar","filing":"0001209191-17-014370","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618275/000120919117014370/doc4.xml","form_type":"4"}}]}